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Abstract
Objective : Primary Sjogren’s syndrome (SS) is rarely reported from India. We have studied the clinical
spectrum and immunological profile of patients with primary SS.
Methods : A prospective analysis of patients with primary Sjogren’s syndrome fulfilling San Francisco
criteria, seen at our clinic in  the last 10 years was carried out.
Results : The study included 26 patients, 21 being women. The presenting symptoms included dry
eyes, dry mouth, and arthritis/ arthralgia. Extra-glandular manifestations were glomerulonephritis, vasculitis,
renal tubular acidosis and peripheral neuropathy. The important laboratory abnormalities were
hypergammaglobulinaemia (16/20), antinuclear antibodies (18/26), anti-La (11/19) and anti-Ro (10/19).
Minor salivary gland provided a definitive diagnosis in 16/26 (60%).
Conclusion : The prevalence of primary Sjogren’s syndrome is rare even in tertiary care rheumatology
clinics. The clinical and immunological profile as seen here is similar to that reported in Western countries.
instillation was carried out to confirm xerophthalmia. Lack of
salivary pool was taken as indicative of xerostomia.
Associated autoimmune diseases like rheumatoid arthritis,
systemic lupus erythematosus, systemic sclerosis and
inflammatory myositis were excluded. Patients of sicca
syndrome without any other associated disease underwent
minor salivary gland biopsy and autoantibody screen. Only
cases who fulfilled the San Francisco criteria 6 for diagnosis
of SS are included in this report. Presence of dry eyes, dry
mouth, and salivary gland swelling, extra-glandular features,
Schirmer’s test were noted along with results of laboratory
investigations. Sera samples were stored at -70°C at the first
visit of the patient and were analyzed later.
All patients underwent minor salivary gland biopsy from
the lower lip. Briefly 5-6 glands were removed after making a
small incision on the mucosa just inferior to lower lip. The
tissue was fixed in formalin and histopathological scoring for
lymphocytic infiltration was done using Chishlom and Mason
grading.7 Briefly in this, the infiltrate in a 4 mm square area is
graded on a scale of 0-4. Grade 3 and 4 are diagnostic of SS,
whereas the lower grades are only suggestive.
Antinuclear antibody (ANA) was tested using HEp2 cells
as substrate by indirect immunofluorescence assay. Samples
positive at or above 1:40 dilution were considered to be
positive. Rheumatoid factor was tested using latex
agglutination kit (Ranbaxy diagnostics, India). Serum IgG and
C-reactive proteins were measured by turbidimetric assay
using antibodies from Borenhinger Mannheim , Germany.
Anti-Ro antibodies were detected by counter-
immunoelectrophoresis using human spleen extract prepared
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INTRODUCTION
Sjogren’s syndrome (SS) is an autoimmune exocrinopathyinvolving lacrimal and salivary glands. This leads to
progressive destruction of the glands resulting in dry eyes
and dry mouth, the two cardinal symptoms of the disease. It
may exist alone (primary Sjogren’s syndrome or may occur in
association with other connective tissue diseases (secondary
Sjogren’s syndrome). SS, although a common disorder in
Western countries with an estimated prevalence of 3 in 100 to
1 in 1000,1 has rarely been reported from India.2-5 Lack of
awareness of this entity by attending physicians, ophthalmic
surgeons and dentists may be one of the factors. Even
rheumatology centers have reported this disease infrequently.
Our clinic and laboratory was fully functional in 1990 and
since then we have actively sought to identify SS amongst
all rheumatology patients.  There were two objectives when
we initiated the study; 1) to see how common is the problem
and 2) to see if there were any phenotypic differences from
that reported in western literature.
METHODS
All patients attending the rheumatology outpatient were
questioned regarding the presence of dry eyes and/or dry
mouth. If present, Schirmer’s test and tear film breakage time
or conjunctival erosion detection by 1% fluorescein dye
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in-house. Anti-La antibodies were tested by Western blotting
using rabbit thymus extract as the antigen.
RESULTS
There were 26 patients; 21 being women. Their mean age
was 42.7years (range 18-60 years) and the mean duration of
symptoms was 4.15 years (range 0.5-10 years).  Symptom of
dry eyes was present in 22 and dry mouth in 23 of the 26
patients. Parotid gland enlargement was present in six patients.
Extra-glandular symptoms included arthritis in 20, small vessel
vasculitis,3 glomerulonephritis,2 renal tubular acidosis,1 and
peripheral neuropathy.1
Referral diagnosis in 22 was polyarthritis or rheumatoid
arthritis. Three cases came to endocrine surgery with recurrent
parotid swelling was sent to us by them and one patient was
sent by dentist. Only two patient had seen an ophthalmologist.
Majority had elevated erythrocyte sedimentation rate,
normal (<0.5 mg/dL) C reactive proteins and high serum IgG
levels (Table 2). No erosions were detected in the radiographs
of the hand joints from these patients. Autoantibodies
present were as follows; rheumatoid factor (15 /26), anti-
nuclear antibodies (speckled pattern) (18/25), anti-La
antibodies (11/19) and anti-Ro (10/19) antibodies.
Cryoglobulins were present in both the patients with
glomerulonephritis.
Minor salivary gland biopsy (Fig. 1) was diagnostic in 15/
26 patients whereas in rest it showed only grade I/II changes
(Table 2). Thus 15 patients had definite SS whereas 11 had
probable SS.
Symptomatic treatment included artificial tears, frequent
use of sips of water and care of teeth. Corticosteroids (1mg/
Kg/day to start with and later tapered over a period of six
months) were used only in patients with glomerulonephritis
and vasculitis. Immunosuppressive drugs like azathioprine
or cyclophosphamide were not used. Arthritis was managed
with NSAIDs and low dose methotrexate (7.5 -15mg/week) or
hydroxychloroquine (3-5 mg/kg/day).
On follow-up one patient with glomerulonephritis
progressed to end-stage renal disease and was later lost to
follow up.
Fig. 1 : One large focus of lymphocytes and plasma cells around a
duct replacing the acini  100X HE stain (Chishlom grade 3)
Table 1: Clinical features of 26 patients with primary Sjogren’s syndrome
Pt. No. Age (y)/Sex Duration (y) Dry Eyes Dry Mouth Articular involvement Extra-glandular features
1 18/F 8 + + + —
2 35/F 2 + + + SC nodules
3 40/F 0.5 - + - —
4 60/F 2 + + + —
5 60/F 2 + + + Purpura, Neuropathy
6 37/M 5 + - + —
7 59/F 3 + + + Purpura
8 52/F 6 + + - —
9 25/M 10 + + + —
10 48/F 8 + - + —
11 35/F 4 - + - GN
12 57/F 2 - + + —
13 41/F 2 + + + —
14 28/F 4 + + + Purpura
15 32/F 1 + + + —
16 40/F 2 + + + —
17 50/M 7 + - + —
18 22/F 1 + + + —
19 48/F 2 + + + —
20 59/M 1 + + + —
21 56/F 10 + + + —
22 43/M 10 + + + —
23 35/F 12 + + + Purpura, GN
24 49/F 1 + + - —
25 55/F 0.3 + + - —
26 26/F 2 - + - RTA
 y- years, F- females, M - males, +  - present, - - absent, SC - subcutaneous, GN- glomerulonephritis, RTA- renal tubular acidosis.
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DISCUSSION
SS has been infrequently reported from the Indian
subcontinent. This report highlights the rarity of this disease
in our geographic region. Eventhough ours is a dedicated
clinic for rheumatic diseases, catering to a population of over
35 million, primary SS constitutes only about 0.5 % of all
patients seen during the last 10 years. Over the same period
2122 patients with rheumatoid arthritis, 995 patients with
seronegative spondyloarthropathies, 474 patients with
systemic lupus erythematosus, 197 patients with systemic
sclerosis, and  301 patients with juvenile chronic arthritis and
a few patients with other rheumatic diseases were seen. This
is partly related to the scant attention given to problems of
dry eyes and dry mouth by the patient and also lack of
awareness on the part of the attending physician to make a
diagnosis of SS and refer the patient to a rheumatologist. Of
the 26 patients presented here, an ophthalmologist had seen
only two and none had been suspected of the disease. A
population based study4 of rheumatic diseases in India,
conducted by a rheumatology center makes no mention of
this disease; whereas in Western countries the prevalence
varies depending upon the criteria used, thus using the
European Economic Criteria in Europe the prevalence is 1-
3%, whereas using the San Diego or San Francisco criteria
the figure is 0.5% in USA.8 This is unlikely to be due to the
lack of susceptible HLA allele in India as HLA DR3 is present
in 25% of North Indian population in our area.9
Rheumatoid arthritis can closely mimic primary SS due to
the presence of symmetrical inflammatory polyarthritis and
rheumatoid factor thus most patients were referred to us with
a misdiagnosis of RA. The absence of deformities, joint
erosions on hand radiographs, normal CRP values, marked
hyper-gammaglobluinemia, presence of anti-La antibodies
helps in distinguishing primary SS from SS associated with
rheumatoid arthritis. The increased prevalence of articular
manifestations in our cohort may be because of this referral
bias.
The controversy surrounding the diagnostic criteria of SS
persists and there are as many as seven different criteria with
varying specificities and sensitivities.4 Most of them require
sophisticated instruments and cumbersome procedures like
salivary scintigraphy, parotid sialography and saliva flow
rate measurements, which are unlikely to be available at most
centers in India. Thus we feel that in developing countries,
schirmer’s test for dry eyes, lack of salivary pool for dry
mouth along with speckled ANA positivity and minor salivary
gland biopsy should suffice to make diagnosis of SS in
majority of cases.
There is a reservation of getting a biopsy both by patients
and physicians, and many rheumatologists feel that
documentation of dry eyes and dry mouth along with
presence of antibodies abrogates the need for salivary gland
biopsy10. In our country, where autoantibody testing is still
not widely available, biopsy is a simple and definitive test for
Table 2: Laboratory features of  26 patients with primary Sjogren’s syndrome.
Pt. No. ESR CRP IgG RF ANA Anti-Ro Anti-La Labial Bx
1 72 <0.5 5230 24 + + + IV
2 35 <0.5 5760 — + + - III
3 48 <0.5 7220 — + - - II
4 55 <0.5 6150 384 + + + II
5 NA 18.3 5360 1432 + + - II
6 14 1.6 605 384 + + + IV
7 31 <0.5 5510 384 - - + I
8 58 <0.5 960 96 + - + IV
9 24 <0.5 1940 192 + - + I
10 27 <0.5 2040 24 NA NA NA I
11 74 <0.5 11400 — + - + IV
12 NA <0.5 2430 — + + + IV
13 NA 1.8 2570 384 + - - III
14 59 1.5 6380 — + + + II
15 57 0.8 NA 192 + - - II
16 58 <0.5 NA 96 - + NA I
17 60 <0.5 5060 — - NA - III
18 NA <0.5 1110 384 + NA + IV
19 21 0.57 NA — - + NA IV
20 46 <0.5 10,700 — - NA NA III
21 30 1.34 1130 — - NA NA II
22 43 <0.5 1410 80 - NA NA III
23 34 NA NA 80 + NA NA IV
24 25 <0.5 NA — + - - IV
25 NA NA NA — + + - I
26 50 — 4130 80 + - + III
ESR-Erythocyte sedimentation rate in mm/hr by Westergren’s method, CRP- C reactive protein in mg/dl, IgG - Immunoglobulin G in mg/dl, RF -
Rheumatoid factor as reciprocal of titer, ANA- antinuclear antibodies, anti Ro/La - antibodies to Ro (SSA) or La (SSB), +  - present, - - negative;
NA- not available, Labial biopsy score as per Chisholm and Mason grading.
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diagnosis if adequate tissue is collected at biopsy. It also
helps in excluding diagnosis like tuberculosis, sarcoidosis
and lymphoma, which may mimic the clinic picture of SS. We
encountered one patient each with a diagnosis of tuberculosis
and sarcoidosis, which was revealed on labial salivary gland
biopsy.
The mean age of our patients is 10 years younger than
that reported from Europe. Ten patients out of 26 were below
the age of 40 years. The same “shift to the left” phenomenon
has been observed with many diseases in India and is
probably due to less proportion of geriatric patients in our
population. Our gender bias for females is also less as
compared to 9:1 reported from West.1
Eventhough we had two cases with glomerulonephritis, it
is a rare renal manifestation of primary SS. The most common
renal manifestation is interstitial nephritis  which is usually
asymptomatic1 or can present with distal renal tubular
acidosis. One of our patient had hypokalemic quadriparesis
due to distal renal tubular acidosis as the first complaint and
went on to develop symptoms of dry mouth with severe dental
caries after a period of one year. We did not investigate to
look for sub-clinical tubular dysfunction in other patients
although it has been suggested.
The prevalence of various autoantibodies in present series
is similar to that reported in other series.1 In variance with
other reports we found three patients having anti-La
antibodies in the absence of anti-Ro antibodies. It may be
related to use of immunoblotting for the detection of anti-La,
which is a more sensitive method than counter-
immunoelectrophoresis used for detection of anti-Ro.11
One of the drawbacks of our study is lack of data on
hepatitis C virus infection in these patients which has recently
been shown to present in the same way. However, the presence
of autoantibodies in majority of our patients excludes this
possibility as they are absent in patients with hepatitis C
infection.12 HIV infection may also cause SS and testing for it
should be done in high-risk individuals presenting with sicca
syndrome.
Thus, in conclusion primary SS is an uncommon and
under-diagnosed entity in India. Definitive primary SS with
classical history of sicca syndrome is less often seen than
probable cases. We feel that the San Francisco criteria are
more suitable for our country. Further, there is a need for a
collaborative, multi-center study to know the exact prevalence
of primary SS in our hospitals.
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